Product Information
FT TRIPLE ANTIBIOTIC-PAIN OINT is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.1293 per GM under NDC 70677121901. Its NADAC has been published 99 times since Aug 7, 2024.
FT TRIPLE ANTIBIOTIC-PAIN OINT
Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine HydrochlorideStrength
500; 3.5; 10000; 10 [USP'U]/g; mg/g; [USP'U]/g; mg/g
Manufacturer
Strategic Sourcing Services LLCNDC
70677121901
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Last Updated
6/17/2026
Approval Type
OTC MONOGRAPH DRUG
FDA Application
M004On Market Since
1/29/2024
Pharmacological Classes
Price Statistics
The NADAC for FT TRIPLE ANTIBIOTIC-PAIN OINT has been published 99 times since Aug 7, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1293 per GM |
|---|---|
| All-time high | $0.1315 (Oct 16, 2024) |
| All-time low | $0.1246 (Apr 23, 2025) |
| 52-week high | $0.1293 |
| 52-week low | $0.1265 |
| Median price | $0.1277 |
| Average price | $0.1275 |
| Largest weekly change | -4.7% (Oct 23, 2024) |
| Weeks tracked | 99 |
| Tracking since | Aug 7, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FT TRIPLE ANTIBIOTIC-PAIN OINT?
The current National Average Drug Acquisition Cost (NADAC) for FT TRIPLE ANTIBIOTIC-PAIN OINT, manufactured by Strategic Sourcing Services LLC, is $0.1293 per GM (NDC 70677121901), effective Jun 24, 2026.
How has the price of FT TRIPLE ANTIBIOTIC-PAIN OINT changed over time?
Over the history we have for it, the NADAC for FT TRIPLE ANTIBIOTIC-PAIN OINT has held within roughly two percent of its current level. It has been tracked across 99 weekly CMS publications since Aug 7, 2024.
What are the highest and lowest recorded NADAC prices for FT TRIPLE ANTIBIOTIC-PAIN OINT?
Since Aug 7, 2024, the NADAC for FT TRIPLE ANTIBIOTIC-PAIN OINT has ranged from a low of $0.1246 (Apr 23, 2025) to a high of $0.1315 (Oct 16, 2024), with a median of $0.1277 per GM.
Are there cheaper alternatives to FT TRIPLE ANTIBIOTIC-PAIN OINT?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, HM TRIPLE ANTIBIOTIC PLUS OINT, is $0.1246 per GM — about 4% below FT TRIPLE ANTIBIOTIC-PAIN OINT.
Who manufactures FT TRIPLE ANTIBIOTIC-PAIN OINT?
FT TRIPLE ANTIBIOTIC-PAIN OINT (NDC 70677121901) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification